Article Text

Download PDFPDF
Randomised controlled trial
An IVC filter and anticoagulation for 3 months is unlikely to show a benefit over anticoagulation alone for high-risk patients with acute pulmonary embolism
  1. Eric K Hoffer
  1. Department of Radiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA
  1. Correspondence to : Dr Eric K Hoffer, Dartmouth Hitchcock Medical Center, Department of Radiology, One Medical Center Drive, Lebanon, NH 03755, USA; hoffer{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMed


Placement of an inferior vena cava (IVC) filter to prevent pulmonary embolism (PE) is recommended by multidisciplinary consensus guidelines only when anticoagulation is contraindicated, has resulted in a complication or has failed.1 ,2 Oddly, the only prospective randomised long-term filter efficacy study that demonstrated a reduction in the recurrent PE rate at 8-year follow-up (6.3% vs 15.1%) did so in a setting where both filter …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.